Compounds > 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran
Page last updated: 2024-09-03

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and sri 63-441

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with sri 63-441 in 1 studies

Compound Research Comparison

Studies
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Trials
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Recent Studies (post-2010)
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Studies
(sri 63-441)		Trials
(sri 63-441)		Recent Studies (post-2010) (sri 63-441)
63006000

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Håkansson, L; Venge, P1

Other Studies

1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and sri 63-441

ArticleYear
Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
    Journal of leukocyte biology, 1990, Volume: 47, Issue:5

    Topics: Azepines; Chemotaxis; Complement C5; Eosinophils; Furans; Humans; Leukotrienes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Quinolinium Compounds; Triazoles

1990